Last reviewed · How we verify

NCT06584305: AI

AI Screening for BDD in Aesthetic Surgery: Enhancing Safety and Outcomes

Completed Last updated 4 September 2024
What this trial tests

trial testing AI-Powered Body Dysmorphic Disorder Screening Procedure in Body Dysmorphic Disorder in 3,722 participants. Completed in 23 August 2024.

Timeline
2 January 2021
Primary endpoint
23 August 2024
23 August 2024

Quick facts

Lead sponsorBukret Plastic Surgery
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3,722
Start date2 January 2021
Primary completion23 August 2024
Estimated completion23 August 2024
Sites1 location across Argentina

Drugs / interventions tested

Conditions studied

Sponsor

Bukret Plastic Surgery

Who can join

18 and older, any sex, with Body Dysmorphic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to evaluate the effectiveness of an AI-powered screening tool for Body Dysmorphic Disorder (BDD) among patients seeking aesthetic surgery. The study aims to determine if the AI system can effectively identify patients at risk for BDD and assess the impact of early psychological intervention on surgical decision-making and outcomes. Participants will complete a comprehensive AI-based risk assessment, which includes the Body Dysmorphic Disorder Questionnaire (BDDQ). The study will track the correlation between BDD, age, stress levels, and gender to better understand the prevalence and implications of BDD in cosmetic surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prospective Evaluation of an Automated Rule-based Screening Tool for Body Dysmorphic Disorder in Aesthetic Surgery.
    Bukret WE. · · 2025 · PMID 41142882 · DOI 10.1097/gox.0000000000007217

Verify or expand the search:

Other recruiting trials for Body Dysmorphic Disorder

Currently open trials in the same condition.

Other Bukret Plastic Surgery trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06584305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing